B Braun L8000 - 0.9% Sodium Chloride Injection USP, 1000 mL, EXCEL IV Container (Rx), 12/CS

B Braun L8000 - 0.9% Sodium Chloride Injection USP, 1000 mL, EXCEL IV Container (Rx), 12/CS

B Braun L8000 0.9% Sodium Chloride Injection USP, 1000 mL, EXCEL IV Container

0.9% Sodium Chloride Injection USP is indicated for extracellular fluid replacement, treatment of metabolic alkalosis in the presence of fluid loss and mild sodium depletion.

• These intravenous solutions are indicated for use in adults and pediatric patients as sources of electrolytes and water for hydration
• Sterile, nonpyrogenic, and contain no bacteriostatic or antimicrobial agents
• Packaging is not manufactured with PVC or DEHP
• Specific Gravity: 1.006

Each 100 mL of 0.9% Sodium Chloride Injection USP contains:

• Sodium Chloride USP 0.9 g; Water for Injection USP qs
• pH: 5.6 (4.57.0) Calculated Osmolarity: 310 mOsmol/liter
• pH adjusted with Hydrochloric Acid NF
• Concentration of Electrolytes (mEq/liter): Sodium 154, Chloride 154

The plastic container is made from a multilayered film specifically developed for parenteral drugs. It contains no plasticizers and exhibits virtually no leachables. The solution contact layer is a rubberized copolymer of ethylene and propylene. The container is nontoxic and biologically inert. The container-solution unit is a closed system and is not dependent upon entry of external air during administration.

The container is overwrapped to provide protection from the physical environment and to provide an additional moisture barrier when necessary.

Addition of medication should be accomplished using complete aseptic technique.

The closure system has two ports; the one for the administration set has a tamper evident plastic protector and the other is a medication addition site. Refer to the Directions for Use of the container.

Indications and Usage

These intravenous solutions are indicated for use in adults and pediatric patients as sources of electrolytes and water for hydration.

0.9% Sodium Chloride Injection USP is indicated for extracellular fluid replacement, treatment of metabolic alkalosis in the presence of fluid loss and mild sodium depletion.

0.9% Sodium Chloride Injection USP is also indicated for use as a priming solution in hemodialysis procedures and may be used to initiate and terminate blood transfusions without hemolyzing red blood cells.

Sodium Chloride Injections USP are also indicated as pharmaceutic aids and diluents for the infusion of compatible drug additives. Refer to prescribing information accompanying additive drugs.

How are B. Braun IV containers different from those that contain PVC?

B. Braun IV containers are biologically inert and are not made with natural rubber latex, PVC or the plasticizer DEHP. When certain medications come in contact with PVC, there is potential for sorption of the drug and therefore the release of DEHP into the fluid and/or absorption of the active ingredient with subsequent sub-therapeutic dosing. Using B. Braun IV containers minimizes patient exposure to the toxic DEHP plasticizer compared to using PVC containers containing DEHP.